Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review - Quiz - MDSpire

Adverse Events Related to Treatment and Quality of Life Outcomes in Patients with Mucosal Head and Neck Squamous Cell Carcinoma Undergoing Immune Checkpoint Inhibitor Therapy: A Scoping Review

  • By

  • N. D. O'Donnell

  • E. C. Ward

  • L. R. Wishart

  • R. Perera

  • C. Barrett

  • K. A. Edmiston

  • E. Mitchell

  • A. Pigott

  • R. Pitt

  • K. Russell

  • B. A. Chan

  • R. Ladwa

  • June 1, 2026

Share

Original Source(s)

Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

  • by N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa

  • June 1, 2026

Related Content

Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

SCC-Net: A lightweight attention-enhanced deep learning model for automated squamous cell carcinoma detection